Comparison between anti-Müllerian hormone and antral follicle count for assessment of ovarian reserve
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20252317Keywords:
Pregnancy, Anti-müllerian hormone, Antral follicle count, InfertilityAbstract
Background: In general, anti-müllerian hormone (AMH) is positively associated with antral follicle count (AFC). AMH and AFC are correlated with the ovarian response, but their reliability and reproducibility are questionable.
Methods: This is a prospective observational study. A total of 50 patients were selected who visited the hospital for infertility treatment. It was conducted in SKIMS MCH Srinagar over a period of 4 months from January 2023 to April 2023. Karl Pearson’s correlation coefficient was employed for assessing correlation between AMH levels and Total AFC. A P value of less than 0.05 was considered statistically significant.
Results: Total of 50 patients were included in the study with mean age of patients being 34.1. The mean BMI of patients was 27.1 and mean duration of infertility was 3.6years. Mean±SD of AFC between age group 26 to 30 was 6.41±9.65 between 31 to 35 was 5.60±4.42 and between 36 to40 was 2.76±2.34, with a p value of 0.012 (statistically significant). Mean±SD of AMH between age 26 to30 was 2.10±1.98 between age 31to35 was 1.83±2.19 and between age 36 to40 was 0.49±0.72.
Conclusion: AMH is considered as most reliable investigation for ovarian reserve testing. However, AFC can be used in place of AMH in poor patients as the cost of AMH is more as they have a strong corelation.
Metrics
References
Practice committee of the American society for reproductive medicine. testing and interpreting measures of ovarian reserve: A committee opinion. Fertil Steril. 2015;103:9-17. DOI: https://doi.org/10.1016/j.fertnstert.2014.12.093
Tal R, Seifer DB. Ovarian reserve testing: A user’s guide. Am J Obst Gynaecol. 2017;217:129-40.
Weenen C. Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Antimullerian hormone expression pattern in human oovary: Potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77‑83. DOI: https://doi.org/10.1093/molehr/gah015
Gougeon A, Echochard R, Thalabard JC. Age‑related changes of the population of human ovarian follicles: Increase in the disappearance rate of nongrowing and early‑growing follicles in aging women. Biol Reprod. 1994;50:653‑63. DOI: https://doi.org/10.1095/biolreprod50.3.653
BroekmansFJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests of predicting ovarian reserve and IVF outcome. Hum Reprod. 2006;12:685‑718. DOI: https://doi.org/10.1093/humupd/dml034
Moslehi N, Shab-Bidar S, Ramezani Tehrani F, Mirmiran P, Azizi F. Is ovarian reserve associated with body mass index and obesity in reproductive aged women. A meta-analysis Menopause. 2018;25(9):1046–55. DOI: https://doi.org/10.1097/GME.0000000000001116
Hadlow N, Longhurst K, McClements A, Natalwala J, Brown SJ, Matson PL. Variation in antimullerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response. Fertil Steril. 2013;99:1791–7. DOI: https://doi.org/10.1016/j.fertnstert.2013.01.132
Lee JY, Ahn S, Lee JR, Jee BC, Kim CH, Seo S, et al. Reference values for the revised anti-Müllerian hormone generation II assay: infertile population-based study. Korean Med Sci. 2017;32(5):825–9. DOI: https://doi.org/10.3346/jkms.2017.32.5.825
Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94:1044–51. DOI: https://doi.org/10.1016/j.fertnstert.2009.04.040
Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol 2017;217(2):129–40. DOI: https://doi.org/10.1016/j.ajog.2017.02.027
Magnusson A, Oleröd G, Thurin-Kjellberg A, et al. The correlation between AMH assays differs depending on actual AMH levels. Hum Reprod Open. 2017;2017(4):1093. DOI: https://doi.org/10.1093/hropen/hox026
Moolhuijsen LME, Visser JAJ. Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab 2020;105(11):3361–73. DOI: https://doi.org/10.1210/clinem/dgaa513
Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N. A prospective, comparative analysis of anti- Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril. 2010;93:855–64. DOI: https://doi.org/10.1016/j.fertnstert.2008.10.042
Barbakadze L, Kristesashvili J, Khonelidze N, Tsagareishvili G. The correlations of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women. Int J Fertil Steril. 2015;8:393–8.
Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, Escobar Morreale HF. Definition and significance of polycystic ovarian morphology: a task force report from the Androge. Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2014;20:334–5 DOI: https://doi.org/10.1093/humupd/dmt061
Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod. 2015;21(6):698–710. DOI: https://doi.org/10.1093/humupd/dmu062
Broer SL, Eijkemans MJ, Scheffer GJ. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96(8)2532–9. DOI: https://doi.org/10.1210/jc.2010-2776
Bentzen JG, Forman JL, Johannsen TH. Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging. J Clin Endocrinol Metab. 2013;98(4):1602–11. DOI: https://doi.org/10.1210/jc.2012-1829
Downloads
Published
How to Cite
Issue
Section
